- Home
- PLUR vs SCOR Comparison
PLUR vs SCOR Comparison
Compare PLUR & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- SCOR
- Stock Information
- Founded
- PLUR 2001
- SCOR 1999
- Country
- PLUR Israel
- SCOR United States
- Employees
- PLUR N/A
- SCOR N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- SCOR Business Services
- Sector
- PLUR Health Care
- SCOR Consumer Discretionary
- Exchange
- PLUR Nasdaq
- SCOR Nasdaq
- Market Cap
- PLUR 37.6M
- SCOR 34.6M
- IPO Year
- PLUR N/A
- SCOR 2007
- Fundamental
- Price
- PLUR $4.48
- SCOR $8.05
- Analyst Decision
- PLUR Strong Buy
- SCOR
- Analyst Count
- PLUR 1
- SCOR 0
- Target Price
- PLUR $12.00
- SCOR N/A
- AVG Volume (30 Days)
- PLUR 9.3K
- SCOR 157.5K
- Earning Date
- PLUR 11-11-2025
- SCOR 11-11-2025
- Dividend Yield
- PLUR N/A
- SCOR N/A
- EPS Growth
- PLUR N/A
- SCOR N/A
- EPS
- PLUR N/A
- SCOR N/A
- Revenue
- PLUR $1,336,000.00
- SCOR $358,513,000.00
- Revenue This Year
- PLUR $246.11
- SCOR $3.45
- Revenue Next Year
- PLUR $169.62
- SCOR $2.59
- P/E Ratio
- PLUR N/A
- SCOR N/A
- Revenue Growth
- PLUR 309.82
- SCOR N/A
- 52 Week Low
- PLUR $3.33
- SCOR $4.39
- 52 Week High
- PLUR $7.13
- SCOR $10.18
- Technical
- Relative Strength Index (RSI)
- PLUR 46.99
- SCOR 61.88
- Support Level
- PLUR $4.08
- SCOR $8.31
- Resistance Level
- PLUR $4.50
- SCOR $10.18
- Average True Range (ATR)
- PLUR 0.22
- SCOR 0.52
- MACD
- PLUR -0.02
- SCOR 0.06
- Stochastic Oscillator
- PLUR 65.05
- SCOR 49.77
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.